HOME >> BIOLOGY >> NEWS
Mount Sinai School of Medicine and Bionostra Group collaborate to develop avian flu vaccine

The Mount Sinai School of Medicine announced today it will collaborate with the prestigious Bionostra Group of Spain to develop an avian flu vaccine. The vaccine will protect against the lethal infection of the H5N1 virus.

Founded in 2000, Bionostra - - in collaboration with members of the Consejo Superior de Investigaciones Cientficas (CSIC) which is the Spanish High Council of Scientific Research - - has developed a new technology based on virus-like-particles to provide a new generation of vaccines for human and animal health. These novel technology, will offer researchers at Mount Sinai School of Medicine a great jumping off point in the creation of the vaccine.

"We are enthusiastic with this promising collaboration between Bionostra and the Mount Sinai School of Medicine which is renowned for its prestigious scientific research," said Juan Carlos del Castillo Tamayo, CEO of Bionostra. "This is the first step for a revolutionary new generation of vaccines against the influenza virus."


'"/>

Contact: Lucia Lee
lucia.lee@mountsinai.org
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
29-Mar-2006


Page: 1

Related biology news :

1. Climate change isolates Rocky Mountain butterflies
2. Bernese Mountain Dogs prone to Borrelia burgdorferi infection
3. Bronfman gift to Mount Sinai catalyzes genomics-based medicine
4. NIH establishes Center of Excellence for influenza research at Mount Sinai
5. Mount Sinai School of Medicine licenses avian flu vaccine to Avimex
6. Sensational find: The mini-dinosaurs from the Harz Mountains
7. Brookhaven Lab and Mount Sinai form joint Center for Translational Biomedical Imaging
8. University of Kentucky author captures national attention with Lost Mountain
9. Infectious disease expert warns of spread of Rocky Mountain spotted fever
10. Mount Sinai receives NIH funding for stem cell research
11. Enzyme deficiency may contribute to liver cancer, Mount Sinai research indicates

Post Your Comments:
(Date:5/24/2013)... 24, 2013 A frequently expressed concern in the ongoing ... fresh vegetables, especially those that are nutrient dense. ... and Beans Provide Most Nutrients Per Penny," published in ... are one of the best nutritional values in the ... per penny than most other raw vegetables and delivering ...
(Date:5/24/2013)... world,s largest and fastest growing open-access publishers, today announces ... Physics . , A broad scope journal covering all ... open-science and interactive web platform for the research community ... , Frontiers, real-time and interactive peer-review enables fast, fair ... With an average of three months from submission to ...
(Date:5/24/2013)... immune system to combat metastatic cancer , Cancer ... by the immune system. Stimulation of the immune system ... many factors that cause the immune system to ignore ... function to suppress the immune system response. In this ... researchers led by Ronald Levy at Stanford University found ...
Breaking Biology News(10 mins):New research shows that potatoes provide one of the best nutritional values per penny 2Frontiers launches new open-access journal in physics 2Frontiers launches new open-access journal in physics 3JCI early table of contents for May 24, 2013 2JCI early table of contents for May 24, 2013 3JCI early table of contents for May 24, 2013 4JCI early table of contents for May 24, 2013 5JCI early table of contents for May 24, 2013 6JCI early table of contents for May 24, 2013 7JCI early table of contents for May 24, 2013 8
(Date:5/24/2013)... Vestiage, Inc. (stock symbol "VEST") a publicly traded ... development, sales and marketing of premium branded highly ... it is awarding exclusive Vestiage territories in the ... Illuminating Facial Care. Qualified applicants can request an ... to info(at)vestiageinc(dot)com and putting RELUMA in the "Subject" ...
(Date:5/23/2013)... May 23, 2013  BioScrip, Inc. (NASDAQ: ... at the Jefferies 2013 Global Healthcare Conference to be ... York. Richard Smith , ... Tran , Chief Financial Officer, will present on ... Time.   About BioScrip BioScrip, Inc. ...
(Date:5/23/2013)... BROWNSBURG, Ind. , May 23, 2013  Rahal ... leader in human cord blood stem cell banking and ... sponsor of the No. 16 Acorn Stairlifts Indy car ... is for the remainder of the IZOD IndyCar 2013 ... Racing (RLL) will work to support awareness of umbilical ...
(Date:5/23/2013)... , May 23, 2013 Virobay, Inc. today ... pain has reached an important milestone, as Virobay has ... - a selective cathepsin S inhibitor.   ... double-blind, randomized, placebo-controlled study designed to evaluate the safety, ... in healthy adults. "The initiation of this ...
Breaking Biology Technology:Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 2Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 3Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 4Vestiage Announces Launch of Exclusive Territories for Reluma Brand Sales in USA 5StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 2StemCyte, Inc. Joins Rahal Letterman Lanigan Racing As Associate Sponsor Of No. 16 IndyCar Program For James Jakes Beginning With The 97th Indianapolis 500 3Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 2Virobay, Inc. initiates a Phase 1 Trial of VBY-036, a compound intended for the treatment of neuropathic pain 3
Cached News: